β₂-AR Antibodies

Santa Cruz Biotechnology features a diverse variety of β₂-AR monoclonal antibodies for investigating the β₂-adrenergic receptor's role in various physiological processes. β₂-AR monoclonal antibodies are validated for multiple experimental applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The β₂-adrenergic receptor is a central component of the adrenergic signaling pathway, primarily involved in mediating the effects of catecholamines like epinephrine and norepinephrine. β₂-adrenergic receptors play a significant role in regulating cardiovascular function, smooth muscle relaxation, and metabolic processes. Research focused on β₂-adrenergic receptor function has proven vital for developing therapeutic strategies for conditions such as asthma, heart failure, and obesity. Advanced research techniques utilizing β₂-AR monoclonal antibodies enable detailed analysis of receptor distribution, activation, and regulation in cellular systems. Investigating β₂-adrenergic receptor signaling pathways provides valuable insights into potential therapeutic targets for various medical conditions. Understanding the molecular mechanisms of β₂-adrenergic receptors continues to advance medical research and drug development. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of β₂-adrenergic receptor biology and its therapeutic applications.